Omada Health (OMDA) Cost of Revenue (2024 - 2026)

Omada Health has disclosed Cost of Revenue across 3 years of filings, most recently posting $29.4 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $29.4 million, up 27.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.0 million (up 33.54% YoY), and the FY2025 annual result was $90.0 million, up 32.31% from the prior year.
• Cost of Revenue came in at $29.4 million for Q1 2026 at Omada Health, up from $24.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $29.4 million in Q1 2026 to a low of $16.4 million in Q2 2024.
• The 3-year median for Cost of Revenue is $22.0 million (2025), against an average of $21.4 million.
• Across the five-year window, Cost of Revenue soared 45.0% in 2025 and rose 27.28% in 2026, its largest moves.
• Omada Health's Cost of Revenue stood at $17.0 million in 2024, then surged by 45.0% to $24.6 million in 2025, then increased by 19.27% to $29.4 million in 2026.
• The last three Cost of Revenue figures came in at $29.4 million (Q1 2026), $24.6 million (Q4 2025), and $22.9 million (Q3 2025), per Business Quant data.